Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
63 hedge funds and large institutions have $191M invested in Marrone Bio Innovations, Inc. in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 7 reducing their positions, and 4 closing their positions.
375% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 4
371% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 7
38% more call options, than puts
Call options by funds: $66K | Put options by funds: $48K
31% more funds holding
Funds holding: 48 → 63 (+15)
30% more capital invested
Capital invested by funds: $146M → $191M (+$44.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$33.8M |
| 2 |
Primecap Management
Pasadena,
California
|
+$17.5M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$7.6M |
| 4 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
+$4.53M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$12.3M |
| 2 |
WFM
Wilmington Funds Management
Wilmington,
Delaware
|
-$223K |
| 3 |
Millennium Management
New York
|
-$189K |
| 4 |
LPL Financial
San Diego,
California
|
-$187K |
| 5 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$74K |
MBII Hedge Fund Activity: Q2 2014 in Review
63 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2014, worth a combined $191M — up 30% from $146M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new MBII positions and 4 closed out — a net gain of 15 holders — while 33 added to existing stakes and 7 trimmed.
The largest buyer was Waddell & Reed Financial, adding an estimated $33.8M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $12.3M.
- 63 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2014, up from 48 in Q1 2014.
- Funds reported $191M of Marrone Bio Innovations, Inc. stock for Q2 2014, up 30% quarter-over-quarter.
- 19 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2014 and 4 closed out, a net change of +15 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q2 2014 was Waddell & Reed Financial, an estimated $33.8M added.
- The largest Marrone Bio Innovations, Inc. seller in Q2 2014 was Gilder Gagnon Howe & Co, an estimated $12.3M sold.
Based on aggregated 13F filings for Q2 2014.